ESMO Preview: Five Key Oncology Battlegrounds To Watch

 
• By Andrew McConaghie

GSK looks to become a cancer contender once again, while Merck and Roche go toe-to-toe in TNBC.

ESMO 2019
• Source: ESMO

More from Anticancer

More from Therapy Areas